Teva pharmaceuticals has issued a voluntary recall of one lot of its reflux medication after discovering that bottles contained tablets of a drug used to treat fluid retention. The recall affects lot ...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the stocks that Jim Cramer shared takes on, along with ...
Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported its third-quarter 2025 financial results on Wednesday, with total revenue of $4.48 billion, beating analysts' expectations of $4.35 billion, ...
JERUSALEM, July 30 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab reported a better than expected increase in second-quarter profit on Wednesday, helped by a 26% rise in sales of ...
Sept 15 (Reuters) - Teva Pharmaceuticals can pursue most of its lawsuit accusing rival drugmaker Corcept Therapeutics of monopolizing the market for the mifepristone-based drug Korlym to treat the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results